Renaissance Technologies - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 13 filers reported holding CYCLO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$28
-100.0%
17,800
-63.3%
0.00%
Q3 2022$94,000
-25.4%
48,494
-24.2%
0.00%
Q2 2022$126,000
-47.5%
63,986
-15.6%
0.00%
Q1 2022$240,000
-2.8%
75,787
+14.3%
0.00%
Q4 2021$247,000
+247.9%
66,300
+532.5%
0.00%
Q3 2021$71,00010,4820.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
XTX Topco Ltd 12,900$18,3180.00%
Virtu Financial LLC 10,732$150.00%
Tower Research Capital LLC (TRC) 6,767$9,6090.00%
JPMORGAN CHASE & CO 240$3410.00%
ROYAL BANK OF CANADA 746$1,0000.00%
VANGUARD GROUP INC 282,027$400,4780.00%
UBS Group AG 88$1250.00%
IFP Advisors, Inc 13$180.00%
OSAIC HOLDINGS, INC. 600$8520.00%
WELLS FARGO & COMPANY/MN 2,352$3,3400.00%
View complete list of CYCLO THERAPEUTICS INC shareholders